Patients likely to save Rs 12,447 crore as a result of fixation of prices of essential medicines

Patients are most likely to save Rs 12,447 crore due to fixation of prices of essential medicines by the government, the Parliament was informed on Tuesday, July 2

Patients likely to save Rs 12,447 crore as a result of fixation of prices of essential medicinesUnion Minister for Chemicals and Fertilizers, D.V. Sadananda Gowda, while giving a written reply to a question on check on drug prices in the country, in Lok Sabha today, stated that the National Pharmaceutical Pricing Authority (NPPA) has taken important measures to check the prices of drugs, under the Drugs (Prices Control) Order (DPCO). He […]

Cancer drugs: NPPA directs manufacturers to furnish details of landing cost

The National Pharmaceutical Pricing Authority (NPPA) has asked the manufactures to submit the details of the landing cost of the drugs imported. The ‘landing cost’ is at which a particular drug is imported in the country

Cancer drugs: NPPA directs manufacturers to furnish details of landing costRecently, the NPPA had capped trade margin of 42 non-scheduled anti-cancer drugs by 30 per cent. The National Pharmaceutical Pricing Authority (NPPA) has issued the order on March 14 directing the manufacturer to furnish the details. The manufacturers will have to submit the landing cost by March 15 with the NPPA. Providing major relief to […]

Cancer: Govt’s proposal for capping drug prices faulty, states Patient’s Rights Groups

The drug price regulator National Pharmaceutical Pricing Authority (NPPA) is expected to cap trade margins of 73 medicines for cancer and rare disease, expanding the span of price control to curtail profiteering on various drugs which are currently outside the purview of government regulation

Cancer: Govt’s proposal for capping drug prices faulty, states Patient’s Rights GroupsWhile the central government is considering this move certain patient’s rights organisation such as Cure SMA Foundation of India, Lysosomal Storage Disorder Support Society (LSDSS), Mr Kishori Lal, a cancer patient, and All India Drug Action Network (AIDAN) have come forward to point out flaws in the government’s plan. A joint statement released by them […]

Government set to regulate medical implants and devices in India

The government’s decision will ensure that medical devices and implants used in India are safe and tested, by bringing all these devices under Indian drug regulator Central Drugs Standard Control Organisation (CDSCO). The agency will become the approving agency for the import, manufacture and sale of the devices in the country

Government set to regulate medical implants and devices in IndiaCome April 2020, the sale, manufacture and import of eight more types of critical medical devices will be regulated by the government to check the supply of faulty equipment The union government in a notification issued on Friday, February 08, 2019 said that medical devices, all implantable devices, CT Scan, PET and MRI equipment, defibrillators, […]

India: NITI Aayog-led panel to monitor drug prices

The Union government has constituted a committee led by NITI Aayog, to monitor the drug prices in India. The NITI-Aayog led panel will recommend the prices of drugs and medicines to National Pharmaceutical Pricing Authority (NPPA)

India: NITI Aayog-led panel to monitor drug pricesThe new order also ends the existing mechanism in which drugs declared essential would automatically come under price control. From now, the NITI Aayog committee will decide which drugs should be under price control. Medicines under price control will be now be identified by a NITI Aayog committee instead of NPPA. The committee will supersede […]

Post fixing of ceiling prices, no shortage of coronary stents reported in India

Mansukh Mandaviya, the Minister of State for Road Transport and Highways, Shipping and Chemicals and Fertilizers. He stated that ceiling prices of 856 medicines have been fixed by the National Pharmaceutical Pricing Authority (NPPA), resulting in a saving of Rs 11,462 crore for patients (as on 30th November 2018)

Post fixing of ceiling prices, no shortage of coronary stents reported in IndiaHe said this while giving a written reply to a question on central government’s initiative of ensuring affordable, quality medicines for all, in Lok Sabha on Wednesday, December 19, 2018. Mandaviya also said that after fixing the ceiling price of coronary stents, NPPA has been closely watching their availability in the country and no shortage […]

Fixation of ceiling prices of medicine resulted in public saving of Rs. 11,463

Till June 2018, the Government has fixed the ceiling prices of 851 medicines (including 4 medical devices i.e. Cardiac stents, drug eluting stents, condoms and intra uterine devices) under Revised Schedule - I based on National List of Essential Medicines, 2015

Fixation of ceiling prices of medicine resulted in public saving of Rs. 11,463Minister of State for Ministry of Road Transport & Highways, Shipping and Chemicals and Fertilisers, Mansukh L. Mandaviya, while giving a written reply to a question on benefits accrued to citizens due to reduction in the prices of essential medicines in recent past, in Lok Sabha today, said that fixation of ceiling prices/MRP of medicines […]

NPPA recovers Rs 827 crore from pharma companies

Since inception of NPPA till February 2018, 1,763 demand notices (including suo-moto deposits) have been issued to pharmaceutical companies for their having overcharged patients on the sale of formulations at prices above the ceiling price notified by NPPA

NPPA recovers Rs 827 crore from pharma companiesThe National Pharmaceutical Pricing Authority (NPPA) monitors the prices of scheduled and non-scheduled formulations on regular basis. It also keeps a check on pharmaceutical companies who overcharge consumers. When such instances occur the NPPA issues notices to the companies responsible for overcharging Recently information was divulged in the Lok Sabha, about pharmaceutical companies overcharging consumers […]

Supreme Court: Medical treatment ‘too expensive,’ Govt has to ‘do something’

The top court’s remark came as it asked the Centre whether any study has been conducted on the effects of air pollution on the health of people and the amounts spent on medical treatment of such ailments

Supreme Court: Medical treatment ‘too expensive,’ Govt has to ‘do something’The Supreme Court of India has taken notice of the spiralling cost of medical treatment in India. It directed the government to ‘do something’ as the common man is unable to get the required treatment owing to the ‘huge cost’ These remarks hold major significance as they come on the lines of National Pharmaceutical Pricing […]

NPPA: ‘To claim higher margin, doctors-hospitals prescribe branded medicine’

Since the analysis done by NPPA is a matter of public concern, it is being up in public domain with the objective of removing information asymmetry between patients and the hospitals and for the greater transparency in healthcare system m in public interest

NPPA: ‘To claim higher margin, doctors-hospitals prescribe branded medicine’On Tuesday evening, the National Pharmacists Pricing Authority (NPPA) tweeted, ‘NPPA uploads analysis of bills of some hospitals based on complaints of overcharging.’ On seeing the upload, a list of medicines, their actual price as well as the profit margin was unveiled. “It is amply clear that for claiming higher margins, doctors and hospitals preferred […]
1 2 3